Update on Waldenstrom's Macroglobulinemia: Somatic Mutation in MYD88 and CXCR4, Review of Available Treatment Options & Ongoing Trials | VuMedi

ESO Lymphoma Course

Update on Waldenstrom's Macroglobulinemia: Somatic Mutation in MYD88 and CXCR4, Review of Available Treatment Options & Ongoing Trials

By ESO Lymphoma Course FEATURING Bernhard Gerber

By ESO Lymphoma Course FEATURING Bernhard Gerber

132 views

September 3, 2019

0 Comments

Login to view comments. Click here to Login